NCI is developing review criteria for a Cancer Center Loan Program that would provide $200 million in loans for capital improvements to qualified centers. NCAB member Eric Lander criticizes limited discussion, “lack of vision” for the loan program.
NCI Director asks NCAB to pray for him.
NCI prepares for third hearing on conflicts of interest.
Waxman urges drug companies to list clinical trials on NIH Web site.
NIH Chemical Genomics Center to screen small molecules.
Knudson wins Kyoto prize; King wins genetics prize.
Funding opportunities listed.
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- In the Headlines: Is oncology ready to move away from animal testing?
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out
- Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?